Skip to content

Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides

Comparison of ESWT and Collagen Hydrolyzed Peptides in the Treatment of Plantar Fascitiis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06138236
Acronym
PFESWTCP
Enrollment
84
Registered
2023-11-18
Start date
2023-07-01
Completion date
2025-12-31
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fascitis

Brief summary

Patients suffering from Plantar Fasciitis were randomized into three groups: the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.

Detailed description

Patients suffering from Plantar Fasciitis were randomized into three groups: the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments. Aim of the study was to consider any difference in the outcome of the three groups of patients. The NRS and the AFAS score were considered for the outcome measurement.

Interventions

infiltration near the heal spur of 2ml of Arthrys

Sponsors

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Patients suffering from plantar fascitiis were randomized into three arms of treatment: Infiltration of collagen hydrolyzed peptides, ESWT and a combination of both treatments

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Plantar fascitiis Aged between 18 and 80 years old

Exclusion criteria

* Previous surgery of the foot * Contraindications to ESWT

Design outcomes

Primary

MeasureTime frameDescription
AFAS is American Foot and Ankle ScaleBetween Recruitment and 30 daysIt is a measurement of active ROM and deambulation of the patient (Range 0-100)
VAS (Visuoanalogic scale)Between recruitment and 30 daysVisuoanalogic Scale during walking. Range 0 (No pain) -10 (maximum pain)
AFAS (American Foot and Ankle Score) is the American Foot and Ankle ScaleBetween Recruitment and 15 daysIt is a measurement of active ROM and deambulation of the patient. Range 0 (no function) -100 (perfect function)

Countries

Italy

Contacts

Primary ContactSilvana DE GIORGI, PI
silvana.degiorgi@uniba.it3389821930

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026